Literature DB >> 12566024

A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

Roy W Beck1, Pamela S Moke, Andrew H Turpin, Frederick L Ferris, John Paul SanGiovanni, Chris A Johnson, Eileen E Birch, Danielle L Chandler, Terry A Cox, R Clifford Blair, Raymond T Kraker.   

Abstract

PURPOSE: To develop a computerized method of visual acuity testing for clinical research as an alternative to the standard Early Treatment for Diabetic Retinopathy Study (ETDRS) testing protocol, and to evaluate its test-retest reliability and concordance with standard ETDRS testing.
DESIGN: Test-retest reliability study.
METHODS: Multicenter setting of a study population of 265 patients at three clinical sites. Visual acuity was measured with both the electronic visual acuity testing algorithm (E-ETDRS) and standard ETDRS protocol (S-ETDRS) twice on one eye of each patient. E-ETDRS testing was conducted using the electronic visual acuity tester (EVA), which utilizes a programmed Palm (Palm, Inc, Santa Clara, California, USA) hand-held device communicating with a personal computer and 17-inch monitor at a test distance of 3 meters.
RESULTS: For the E-ETDRS protocol, test-retest reliability was high (r = 0.99; with 89% and 98% of retests within 0.1 logMAR and 0.2 logMAR of initial tests, respectively) and comparable with that of S-ETDRS testing (r = 0.99; with 87% and 98% of retests within 0.1 logMAR and 0.2 logMAR of initial test, respectively). The E-ETDRS and S-ETDRS scores were highly correlated (r = 0.96 for initial tests and r = 0.97 for repeat tests). Based on estimates of 95% confidence intervals, a change in visual acuity of 0.2 logMAR (10 letters) from a baseline level is unlikely to be related to measurement variability using either the E-ETDRS or the S-ETDRS visual acuity testing protocol.
CONCLUSIONS: The E-ETDRS protocol has high test-retest reliability and good concordance with S-ETDRS testing. The computerized method has advantages over the S-ETDRS testing in electronically capturing the data for each tested letter, requiring only a single distance for testing from 20/12 to 20/800, potentially reducing testing time, and potentially decreasing technician-related bias.

Entities:  

Mesh:

Year:  2003        PMID: 12566024     DOI: 10.1016/s0002-9394(02)01825-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  243 in total

1.  Laterality of amblyopia.

Authors:  Michael Repka; Kurt Simons; Raymond Kraker
Journal:  Am J Ophthalmol       Date:  2010-05-08       Impact factor: 5.258

2.  Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; Mary Elizabeth Hartnett; Geoff Cohen
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

3.  Observational study of subclinical diabetic macular edema.

Authors:  N M Bressler; K M Miller; R W Beck; S B Bressler; A R Glassman; J W Kitchens; M Melia; D K Schlossman
Journal:  Eye (Lond)       Date:  2012-03-23       Impact factor: 3.775

4.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Susan B Bressler; Allison R Edwards; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Kellee M Miller; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2010-04-28       Impact factor: 12.079

5.  Ocular motor and sensory function in Parkinson's disease.

Authors:  Zina Almer; Kathyrn S Klein; Laura Marsh; Melissa Gerstenhaber; Michael X Repka
Journal:  Ophthalmology       Date:  2011-09-29       Impact factor: 12.079

6.  Visual acuity development of children with infantile nystagmus syndrome.

Authors:  Valeria L N Fu; Richard A Bilonick; Joost Felius; Richard W Hertle; Eileen E Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

7.  Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT).

Authors:  Gui-shuang Ying; Maureen G Maguire; Ebenezer Daniel; Frederick L Ferris; Glenn J Jaffe; Juan E Grunwald; Cynthia A Toth; Jiayan Huang; Daniel F Martin
Journal:  Ophthalmology       Date:  2015-09-15       Impact factor: 12.079

8.  Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Neil M Bressler; Wesley T Beaulieu; Adam R Glassman; Kevin J Blinder; Susan B Bressler; Lee M Jampol; Michele Melia; John A Wells
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

9.  Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.

Authors:  Emily Y Chew; Traci E Clemons; Susan B Bressler; Michael J Elman; Ronald P Danis; Amitha Domalpally; Jeffrey S Heier; Judy E Kim; Richard Garfinkel
Journal:  Ophthalmology       Date:  2013-11-08       Impact factor: 12.079

10.  Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

Authors:  Neil M Bressler; Allison R Edwards; Roy W Beck; Christina J Flaxel; Adam R Glassman; Michael S Ip; Craig Kollman; Baruch D Kuppermann; Thomas W Stone
Journal:  Arch Ophthalmol       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.